Document
IPR2017-01995, No. 2054-90 Exhibit - H Koop, Review article metabolic consequences of long term inhibition of acid secretion by omeprazole, Aliment Pharmacol Ther 6399406 1992 (P.T.A.B. J...
Cite Document
IPR2017-01995, No. 2054-90 Exhibit - H Koop, Review article metabolic consequences of long term inhibition of acid secretion by omeprazole, Aliment Pharmacol Ther 6399406 1992 (P.T.A.B. Jun. 1, 2018)
+ More Snippets
Document
IPR2017-01995, No. 2043-80 Exhibit - L Laine, Nonsteroidal anti inflammatory drug gastropathy, Gastrointest Endosc Clin North Am, 63489504 1996 (P.T.A.B. Jun. 1, 2018)
Cite Document
IPR2017-01995, No. 2043-80 Exhibit - L Laine, Nonsteroidal anti inflammatory drug gastropathy, Gastrointest Endosc Clin North Am, 63489504 1996 (P.T.A.B. Jun. 1, 2018)
+ More Snippets
Document
IPR2017-01995, No. 2018-61 Exhibit - Oct 12, 2017 Deposition Testimony of Everardus Orlemans, PhD in the Horizon Pharma, Inc v Dr Reddys Laboratories, Inc, Case No 315 cv 03324 DNJ (P....
Cite Document
IPR2017-01995, No. 2018-61 Exhibit - Oct 12, 2017 Deposition Testimony of Everardus Orlemans, PhD in the Horizon Pharma, Inc v Dr Reddys Laboratories, Inc, Case No 315 cv 03324 DNJ (P.T.A.B. Jun. 1, 2
+ More Snippets
Document
IPR2017-01995, No. 2019-109 Exhibit - Oct 27, 2017 Deposition Testimony of Mark Sostek, MD in the Horizon Pharma, Inc v Dr Reddys Laboratories, Inc, Case No 315 cv 03324 DNJ PROTECT...
Cite Document
IPR2017-01995, No. 2019-109 Exhibit - Oct 27, 2017 Deposition Testimony of Mark Sostek, MD in the Horizon Pharma, Inc v Dr Reddys Laboratories, Inc, Case No 315 cv 03324 DNJ PROTECTIVE ORDER MATERIA
+ More Snippets
Document
IPR2017-01995, No. 2020-110 Exhibit - Oct 25, 2017 Deposition Testimony of Brian Ault, PhD in the Horizon Pharma, Inc v Dr Reddys Laboratories, Inc, Case No 315 cv 03324 DNJ PROTECTIV...
Cite Document
IPR2017-01995, No. 2020-110 Exhibit - Oct 25, 2017 Deposition Testimony of Brian Ault, PhD in the Horizon Pharma, Inc v Dr Reddys Laboratories, Inc, Case No 315 cv 03324 DNJ PROTECTIVE ORDER MATERIAL
+ More Snippets
Document
IPR2017-01995, No. 1056-134 Exhibit - Notice of Appeal District Court (P.T.A.B. Feb. 22, 2019)
Cite Document
IPR2017-01995, No. 1056-134 Exhibit - Notice of Appeal District Court (P.T.A.B. Feb. 22, 2019)
+ More Snippets
Document
IPR2017-01995, No. 1051-126 Exhibit - Sale Order (P.T.A.B. Jan. 4, 2019)
Cite Document
IPR2017-01995, No. 1051-126 Exhibit - Sale Order (P.T.A.B. Jan. 4, 2019)
+ More Snippets
Document
IPR2017-01995, No. 2053-89 Exhibit - JQ Huang RH Hunt, Pharmacological and pharmacodynamic essentials of H2 receptor antagonists and proton pump inhibitors for the practising physician,...
Cite Document
IPR2017-01995, No. 2053-89 Exhibit - JQ Huang RH Hunt, Pharmacological and pharmacodynamic essentials of H2 receptor antagonists and proton pump inhibitors for the practising physician, Best Prac Re
+ More Snippets
Document
IPR2017-01995, No. 2048-85 Exhibit - KS Jain, et al, Recent advances in proton pump inhibitors and management of acid peptic disorders, Bioorganic Medicinal Chemistry 151181 1205 2007 (P...
Cite Document
IPR2017-01995, No. 2048-85 Exhibit - KS Jain, et al, Recent advances in proton pump inhibitors and management of acid peptic disorders, Bioorganic Medicinal Chemistry 151181 1205 2007 (P.T.A.B. Jun.
+ More Snippets
Document
IPR2017-01995, No. 2051-87 Exhibit - L Olbe et al, Reviews A Proton pump inhibitor expedition The case histories of omeprazole and esomeprazole, Nature 2132 139 2003 (P.T.A.B. Jun. 1, 201...
Cite Document
IPR2017-01995, No. 2051-87 Exhibit - L Olbe et al, Reviews A Proton pump inhibitor expedition The case histories of omeprazole and esomeprazole, Nature 2132 139 2003 (P.T.A.B. Jun. 1, 2018)
+ More Snippets
Document
IPR2017-01995, No. 2069-104 Exhibit - M Hassan Alin et al, Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects, Eur J ...
Cite Document
IPR2017-01995, No. 2069-104 Exhibit - M Hassan Alin et al, Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects, Eur J Clin Pharm
+ More Snippets
Document
IPR2017-01995, No. 2013-58 Exhibit - Cryer, B and Feldman, M, Effects of Nonsteroidal Anti inflammatory Drugs on Endogenous Gastrointestinal Prostaglandins and Therapeutic Strategies for ...
Cite Document
IPR2017-01995, No. 2013-58 Exhibit - Cryer, B and Feldman, M, Effects of Nonsteroidal Anti inflammatory Drugs on Endogenous Gastrointestinal Prostaglandins and Therapeutic Strategies for Prevention et
+ More Snippets
Document
IPR2017-01995, No. 2037-74 Exhibit - Meyer, Interaction of Proton Pump Inhibitors with Cytochromes P450 Consequences for Drug Interactions, YALE J BIOL MED, 69203 209 1996 (P.T.A.B. J...
Cite Document
IPR2017-01995, No. 2037-74 Exhibit - Meyer, Interaction of Proton Pump Inhibitors with Cytochromes P450 Consequences for Drug Interactions, YALE J BIOL MED, 69203 209 1996 (P.T.A.B. Jun. 1, 2018)
+ More Snippets
Document
IPR2017-01995, No. 2055-91 Exhibit - Donnellan C, Preston C, Moayyedi P, Sharma N, Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux dis...
Cite Document
IPR2017-01995, No. 2055-91 Exhibit - Donnellan C, Preston C, Moayyedi P, Sharma N, Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease Review,
+ More Snippets
Document
IPR2017-01995, No. 2045-82 Exhibit - C Bombardier et al, Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis, N Engl J Med, 343211520...
Cite Document
IPR2017-01995, No. 2045-82 Exhibit - C Bombardier et al, Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis, N Engl J Med, 343211520¿¿¿1528 2
+ More Snippets